Research Ethics and Policy Series (REPS) | Genevieve Kanter, PhD
The Revolving Door in Health Policy and the FDA Genevieve Kanter, PhD Assistant Professor of Medicine and Medical Ethics, Perelman School of Medicine Register in...
Research Ethics and Policy Series (REPS) | Haresh Kirpalani, MD, MSc and Chris Feudtner, MD, PhD, MPH
The sustained aeration of infant lung (SAIL) RCT: Balancing ethics and the need for evidence Haresh Kirpalani, MD, MSc Emeritus Professor CE of Pediatrics, Perelman...
Research Ethics and Policy Series (REPS) | Holly Fernandez Lynch, JD, MBe
Defining and Advancing IRB Quality and Effectiveness Do you think institutional review boards (IRBs) “work”? What does that mean and how would we know? It turns out...
Research Ethics and Policy Series (REPS): Holly Fernandez Lynch, JD, MBe "Trial Selection and Prioritization at Research Sites: Learning from Oncology and COVID-19"
Trial Selection and Prioritization at Research Sites: Learning from Oncology and COVID-19 Holly Fernandez Lynch, JD, MBe Assistant Professor of Medical...
Research Ethics and Policy Series (REPS) | Jason Karlawish, MD
What just happened? The strange tale of the FDA’s approval of aducanumab for the treatment of Alzheimer’s disease Jason Karlawish, MD Professor of Medicine, Medical...
Research Ethics and Policy Series (REPS): Jennifer Myers, MD / Shivan Mehta, MD, MBA "The Evolution of Quality Improvement Research Ethics"
The Evolution of Quality Improvement Research Ethics Jennifer Myers, MD Professor of Clinical Medicine and the Director of Quality and Safety Education university of...
Research Ethics and Policy Series (REPS) | Jonathan D. Moreno, PhD
Gene editing and geopolitics The controversy about the gene edited babies in China happens to have coincided with increasing tensions between the US and China and...
Research Ethics and Policy Series (REPS): Jonathan Kimmelman, PhD. "Assessing the Scientific Case for Early Phase Trials and/or Innovative Care: the PATH Approach"
Assessing the Scientific Case for Early Phase Trials and/or Innovative Care: the PATH Approach Jonathan Kimmelman, PhD Director of Biomedical Ethics unit mc gill...
Research Ethics and Policy Series (REPS): Justin Clapp, PhD, MPH
Exception from informed consent (EFIC) regulation: Good intentions, indeterminate concepts, bureaucratic absurdities Justin Clapp, PhD, MPH Assistant Professor,...
Research Ethics and Policy Series (REPS) | Karen Glanz, PhD, MPH
Ethical issues in the design & conduct of community-based research The challenges of balancing scientific rigor and ethical concerns in community-engaged research are...